Objectives: The objective of this study is to define novel biomarkers for gastric neoplasm (GN) via in silico analysis that takes GN-specific miRNAs, finds their combinatorial target genes (potential ceRNAs), selects ones containing T-UCR among them and potentiates their relevance with GN. Based on this study we can plan new in vitro and in vivo studies. Methods: Four miRNAs of which clinical relevances with GN were proved experimentally were exported via mirTarbase. Using the ComiR database, 1008 genes targeted by these 4 miRNAs simultaneously were identified. Genes containing T-UCR and showing potential ceRNA activity were extracted. Among GNassociated ceRNAs including T-UCR, we identified genes with significant expression differences between GN and normal stomach tissue using the GEPIA database. The statistical evaluation of the association of NFAT5 and CLK3 genes with GN was performed by Spearman correlation test in GEPIA database. Results: GN-associated ceRNAs cross-matching with genes including T-UCR in their exonic regions were NFAT5 and CLK3. We identified genes with significant expression differences between GN and normal stomach tissues among GN-associated ceRNAs including T-UCR. According to this analysis, only NFAT5 gene was significantly higher expressed in GN than in normal stomach tissue while the other didn't show any significant differential expression pattern. NFAT5 and CLK3 genes were found to be significantly correlated with GN (p<0.001; R=0.22) Conclusion: All in all, this is the study associating NFAT5 gene with GN for the first time and giving it ongogenic potential for GN. Still, larger and more comprehensive studies are needed on this issue.
Introduction
Gastric neoplasms may manifest in various different forms, depending on the cell of origin. The most common form is adenocarcinoma, while lymphoma, gastrointestinal stromal tumors (GISTs), carcinoids and other neoplasms are less frequently seen. Gastric adenocarcinoma is a particularly common cancer across the world, but particularly in the Far East. A lower incidence has been reported in the United Kingdom, but poor prognosis when the disease is in the late stage results in a significant impact on population health. Advanced disease is observed in the majority of patients at time of diagnosis (Schiller, 2017) . MBSJHS; 5(2), 2019
MicroRNAs (miRNAs) are small RNAs that are not encode a protein, but nevertheless potent coordinating capacities. They perform vital regulatory functions in a range of malign cancers, involving gastric cancer. Abnormal stated miRNAs are also involved in gastric carcinogenesis through modification of growth of cells, cell cycles, apoptosis, and migration of cells. Epigenetic and genetic alteration has been identified as one of the mechanisms responsible for miRNA dysregulation. MiRNA performs essential functions in the progression of gastric cancer by targeting oncogene or tumor suppressor gene expression. The first step in determining the roles of miRNAs in gastric cancer is to investigate differences in miRNA expression profiles between normal and tumor gastric tissues (Pan et al., 2013) . Tumor suppressor miRNAs inhibit tumor formation by suppressing oncogenes.
Relationship of microRNAs within cancer changes proteinencoding oncogene or tumor suppressor genes are known to cause cancer. Genetic cause of cancer with the recent demonstration of miRNAs in tumor formation.
Competing endogenous RNAs (ceRNAs) are transcripts capable of mutual regulation at the posttranscription level through competition for shared miRNAs. CeRNA networks link protein-coding mRNA functions with those of non-coding RNAs (ncRNAs), including microRNA, long ncRNA, pseudogenic RNA and circular RNA. Since any transcripts containing an miRNA response component are in theory capable of acting as ceRNAs, these may represent a widespread form of post-transcriptional gene expression regulation in physiological and pathological terms. A number of factors are known to be capable of affecting ceRNA activity, including the abundance and subcellular localization of ceRNA components, the binding affinity of miRNAs to their sponges, RNA editing, RNA secondary structures and RNAbinding proteins. Disturbance in these may lead to deregulation of ceRNA networks and thus to human diseases, including cancer (Qi et al., 2015) .
In recent years, ncRNAs have generated considerable interest in terms of cell transformation. Ultraconserved regions (UCRs) were first discovered in 2004 following bioinformatic investigation of mouse, rat, and human genomes. UCRs consist of a minimum of 481 genomic sequences at least 200 bp in length (range 200-779 bp), and which are fully conserved (100% identity without any insertions or deletions) among the above three vertebrate species. A significant proportion of UCRs are transcribed (T-UCRs) in normal human tissues, and their expression levels have been observed to exhibit a ubiquitous and tissue-specific pattern. While the functions of T-UCRs are largely unclear, the high level of trans-species conservation they exhibit appears to suggest that they are of significant importance to ontogenesis/phylogenesis in mammals. Recent research into genome-wide expression has revealed that T-UCRs exhibit distinct profiles in different human cancers, representing further evidence of their role in carcinogenesis in humans (Fassan et al., 2014) .
In recent years understanding their role in cancer, miRNAs have been hopeful in understanding the molecular pathology of cancer and developing molecular targeted therapies. Based on this feature of miRNAs, we aim to identify genes with potential oncogenic activity not previously identified in silico in gastric cancer. In line with our data, we aim to conduct further in vitro and in vivo studies on these miRNAs
Methods

Selection of miRNAs involved in the pathogenesis of gastric neoplasms
Four miRNAs clinically associated with gastric neoplasm and authenticated experimentally were exported over the MiRTarBase database. The miRTarBase database submits estimated and verified data concerning miRNA-target interaction. This enables researchers to confirm novel miRNA targets. The 'Comfirmed Target module' showed in this study by Chou et al. (2018) .
Analysis of gastric neoplasm-specific miRNAmediated ceRNAs
One thousand eight genes projected by these four miRNAs simultaneously were described using the ComiR database. ComiR is an online system employed for the purpose of combinatorial miRNA target estimation. It computes the potency of targeting by a group of miRNAs. When calculating the relay impact of one mRNA from a group of several miRNAs, the application employs utilizerdefined miRNA expression levels in a combinatorial manner based on appropriate machine learning techniques and thermodynamic modeling to elicit more accurate estimates. ComiR admits the opportunity of constituting a operational target for a group of miRNAs, based on relevant miRNA expression levels, for every gene (Coronnello and Benos, 2013) .
We hope that the RNA transcripts of these genes will exhibit potential ceRNA activity for these miRNAs and that their arrangement is organized on the basis of miRNA-sponging mechanisms.
Matching of GN-associated ceRNA with genes including T-UCR
Bejerano et al. identified the UCRs in the human genome. Genes including these regions are graded as upstream, exonic or downstream in accordance, depending on the site of fixation within the gene (Bejerano et al., 2004) . Genes with T-UCR in their exonic areas were also identified, and those exhibiting latent ceRNA activity were excerpted in our previous research.
Analysis of gastric neoplasm-related ceRNAs including T-UCR in the sense of differential gene expression between gastric neoplasm and normal gastric tissues
Genes exhibiting significant expression differences between gastric neoplasm and normal stomach tissue from GN-associated ceRNAs, including T-UCR were identified with the assistance of the GEPIA database. GEPIA (Gene Expression Profiling Interactive Analysis), a webbased tool to deliver fast and customizable functionalities based on The Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression (GTEx) data. All plotting features in GEPIA are developed using R (version 3.3.2) and Perl (version 5.22.1) programs. (Tang et al., 2017) .
Correl tests of NFAT5 and CLK3 genes in gastric neoplasm
Methods for analyzing gene expression are numerous and diverse. Expression-based clustering, for example, can be divided into supervised and unsupervised methods. Gene expression differential analysis is a classical supervised method, leading to the finding tumorspecific genes by comparing tumor to normal groups. Statistical analysis of the association between NFAT5 and CLK3 genes and gastric neoplasm was showed using the Spearman correlation test in the GEPIA database.
Results
A list of four miRNAs experimentally linked to gastric neoplasm using the miRTarbase database is shown in Table 1 . A list of 1008 genes simultaneously targeted by these four miRNAs is shown supplementary 1. Wedeclared genes with T-UCR in their exonic regions from those listed by Bejerano et al., and these are shown in supplementary 2. Then, we extracted ones showing potential ceRNA activity in our previous analysis among them (Table 2) . Genes exhibiting significant expression variation between gastric neoplasm and normal gastric tissues among gastric neoplasm-related ceRNAs with T-UCR were identified. In agreement with that analysis, expression of NFAT5 was significantly higher in gastric neoplasm compared to normal stomach tissue, while no significant differential expression patterns were detected in the other genes (Table 3) . Table 2 . List of gastric neoplasms-associated ceRNAs cross-matching with genes including T-UCR in their exonic regions NFAT5 CLK3 Table 3 . Expression values of GN-associated ceRNAs including T-UCR between gastric neoplasms and normal stomach tissues. Statistical analysis of the link between NFAT5 and CLK3 genes and gastric neoplasm was conducted through the GEPIA database. Spearman correlation analysis revealed that the NFAT5 and CLK3 gene pair exhibited significant association with gastric neoplasm (Figure 1 ) (p=0.000; R=0.22). 
Discussion
Gastric neoplasm is the leading cause of cancerrelated deaths. According to research conducted in 2008, gastric neoplasm is the fourth most common cancer in the world and ranks second among cancers that cause death. The death rate from this cancer is higher than that from malignant tumors such as colon, breast and prostate cancers. The development of this cancer is complex, involving a number of genetic and epigenetic alterations of oncogenes, tumor suppressor genes, deoxyribonucleic acid (DNA) repair genes, cell cycle regulators, and signaling molecules. Oncogenes are activated at different stages of the course of gastric neoplasm, and some tumor suppressor genes are inactivated. Numerous studies have shown that miRNAs can be effective in carcinogenesis. Changes in expression levels of miRNAs in different types of cancer have been investigated, and miRNAs have been observed to differ between normal and pathological tissues (Sevignani et al., 2006; Zhou et al., 2010) . Various miRNAs have been shown to play a specific role in tumor progression and metastasis in the differentiation of cancer cells (Kim et al., 2011; Calin et al., 2002; Michael et al., 2003; Metzler et al., 2004; Chan et al., 2005; He et al., 2005; Sevli et al., 2010; Lamy et al., 2006; Iorio et al., 2005) The purpose of this study was to describe novel biomarkers for GN through in silico analysis involving gastric neoplasm-specific miRNAs, by determining their combinatorial target genes (potential ceRNAs), selecting those with T-UCR and potentiating their association with gastric neoplasm using statistical correlation techniques.
Four miRNAs experimentally related to gastric neoplasm were identified through the miRTarbase database (Table I) . Genes with equal ComiR abundance were listed through 1008 genes targeted concurrently by these four miRNAs. Genes with T-UCR in their exonic regions were described from the genes containing T-UCR listed by Bejerano et al. (Bejerano et al., 2004) . We then considered those exhibiting probable ceRNA activity in our earlier analysis (Table II ). Next, we choosed genes with significant differences in expression between gastric neoplasm and normal gastric tissues from GN-related ceRNAs involving T-UCR. This test revealed significantly higher NFAT5 expression in gastric neoplasm than in normal stomach tissue, while the other exhibited no significantly different expression pattern. In addition, the NFAT5 and CLK3 gene pair were substantively associated with gastric neoplasm based on the Spearman correlation analysis findings.
These NFAT5 genes have not previously been experimentally linked to gastric neoplasm. Ours is the first study to associate these two genes with gastric neoplasm. NFAT family contains five different proteins one of them is NFAT5 protein.
But, NFAT1 to 4 proteins are regulated by calcineurin, NFAT5 is controlled by osmotic pressure at the nuclear localization, transcriptional and expression levels. When stimulated, NFAT5 triggers target gene transcription by binding to tonicity enhancer elements) in various coordinator domains which are all responsible for supplying cells in order to facilitate their survival under hypertonic conditions (Cheung and Ko, 2017) . NFAT5 gene shows its oncogenic role via different pathways in such diseases as renal cell carcinoma, breast cancer, lung adenocarcinoma and colon cancer. NFAT5-related expression of S100A4 projects the migration and proliferation of renal carcinoma cells (Küper et al., 2014) . Additionally, NFAT5/STAT3 interaction soften synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells (Amara S et al., 2016) . NFAT5 also stimulates the migration and proliferation of pulmonary adenocarcinoma cells, in part by modulating AQP5 expression (Guo and Jin, 2015) . The Src kinase pathway is also involved in NFAT5-mediated S100A4 induction through hyperosmotic stress in colon cancer cells (Chen et al., 2011) . NFAT5 is also a tumor suppressor that functions by suppressing invasion and triggering apoptosis in hepatocellular carcinoma.
Conclusion
The NFAT5 gene was correlated with gastric neoplasm in our study, and in silico analysis results predict that they may potentially play an oncogenic role in gastric neoplasm. The inconsistent results concerning their roles in varying forms of cancer suggests that our study findings will be preliminary for subsequent in vitro and in vivo studies performed to determine the roles of the NFAT5 gene in gastric neoplasm progression. Fatal one among urological cancers. RCC is causedby the accumulation of many genetic and
